DE19547933A1 - Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung - Google Patents

Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung

Info

Publication number
DE19547933A1
DE19547933A1 DE1995147933 DE19547933A DE19547933A1 DE 19547933 A1 DE19547933 A1 DE 19547933A1 DE 1995147933 DE1995147933 DE 1995147933 DE 19547933 A DE19547933 A DE 19547933A DE 19547933 A1 DE19547933 A1 DE 19547933A1
Authority
DE
Germany
Prior art keywords
subunits
metal ions
multimeric
subunit
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE1995147933
Other languages
German (de)
English (en)
Inventor
Kurt Dr Lang
Reinhard Prof Dr Kurth
Michael Dr Baier
Norbert Bannert
Karin Metzner
Albrecht Dr Werner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Bundesrepublik Deutschland
Bundesministerium fuer Gesundheit
Original Assignee
Bundesrepublik Deutschland
Bundesministerium fuer Gesundheit
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bundesrepublik Deutschland, Bundesministerium fuer Gesundheit, Boehringer Mannheim GmbH filed Critical Bundesrepublik Deutschland
Priority to DE1995147933 priority Critical patent/DE19547933A1/de
Priority to JP52328697A priority patent/JP3172968B2/ja
Priority to AU11962/97A priority patent/AU701709B2/en
Priority to DE19681159T priority patent/DE19681159D2/de
Priority to CA002240392A priority patent/CA2240392C/en
Priority to PCT/EP1996/005661 priority patent/WO1997023615A1/de
Priority to EP96943134A priority patent/EP0870029A1/de
Priority to ZA9610766A priority patent/ZA9610766B/xx
Publication of DE19547933A1 publication Critical patent/DE19547933A1/de
Priority to MX9805060A priority patent/MX9805060A/es
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5446—IL-16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE1995147933 1995-12-22 1995-12-22 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung Ceased DE19547933A1 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
DE1995147933 DE19547933A1 (de) 1995-12-22 1995-12-22 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung
JP52328697A JP3172968B2 (ja) 1995-12-22 1996-12-17 Ｉｌ―１６の多量体形態、それらを生産するための方法及びそれらの使用
AU11962/97A AU701709B2 (en) 1995-12-22 1996-12-17 Multimeric forms of IL-16, processes for their production and their use
DE19681159T DE19681159D2 (de) 1995-12-22 1996-12-17 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung
CA002240392A CA2240392C (en) 1995-12-22 1996-12-17 Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof
PCT/EP1996/005661 WO1997023615A1 (de) 1995-12-22 1996-12-17 Multimere formen von il-16, verfahren zu ihrer herstellung und verwendung
EP96943134A EP0870029A1 (de) 1995-12-22 1996-12-17 Multimere formen von il-16, verfahren zu ihrer herstellung und verwendung
ZA9610766A ZA9610766B (en) 1995-12-22 1996-12-20 Multimeric forms of il-16 process for their manufacture and use
MX9805060A MX9805060A (es) 1995-12-22 1998-06-22 Formas multimericas de interleucina-16, proceso para su preparacion y uso de las mismas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1995147933 DE19547933A1 (de) 1995-12-22 1995-12-22 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
DE19547933A1 true DE19547933A1 (de) 1997-06-26

Family

ID=7780879

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1995147933 Ceased DE19547933A1 (de) 1995-12-22 1995-12-22 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung
DE19681159T Ceased DE19681159D2 (de) 1995-12-22 1996-12-17 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19681159T Ceased DE19681159D2 (de) 1995-12-22 1996-12-17 Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung

Country Status (8)

Country Link
EP (1) EP0870029A1 (ja)
JP (1) JP3172968B2 (ja)
AU (1) AU701709B2 (ja)
CA (1) CA2240392C (ja)
DE (2) DE19547933A1 (ja)
MX (1) MX9805060A (ja)
WO (1) WO1997023615A1 (ja)
ZA (1) ZA9610766B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110262390A1 (en) * 1999-04-28 2011-10-27 Genetics Institute, Llc Composition and method for treating inflammatory disorders

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444202B1 (en) 1996-11-25 2002-09-03 Bundesrepublic Deutschland, Vertreten Durch Den Bundesminister Fur Gesundheit Processed polypeptides with IL-16 activity, processes for their production and their use
KR100674528B1 (ko) * 1999-06-28 2007-01-29 제넨테크, 인크. 2가 금속 이온을 사용한 Ａｐｏ-2 리간드 제조 방법
GB0201679D0 (en) * 2002-01-25 2002-03-13 Asterion Ltd Polypeptide variants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
CA1340586C (en) * 1988-09-23 1999-06-08 Cetus Corporation Process for recovering microbially produced interferon-beta
DE69435177D1 (de) * 1993-05-21 2009-02-12 Univ Boston Chemoattraktion-auslösender Faktor aus Lymphozyten und dessen Verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Chem. Abstr. Vol.106(1987) 136733 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110262390A1 (en) * 1999-04-28 2011-10-27 Genetics Institute, Llc Composition and method for treating inflammatory disorders

Also Published As

Publication number Publication date
ZA9610766B (en) 1998-07-01
AU1196297A (en) 1997-07-17
AU701709B2 (en) 1999-02-04
CA2240392A1 (en) 1997-07-03
JP3172968B2 (ja) 2001-06-04
CA2240392C (en) 2001-11-27
DE19681159D2 (de) 1999-07-01
WO1997023615A1 (de) 1997-07-03
JPH11503029A (ja) 1999-03-23
EP0870029A1 (de) 1998-10-14
MX9805060A (es) 1998-10-31

Similar Documents

Publication Publication Date Title
DE69027961T2 (de) Protein, DNA und ihre Verwendung
DE3882593T2 (de) Polypeptid und dessen Herstellung.
AU638402B2 (en) Analogs of fibroblast growth factor
JP2644794B2 (ja) 新規な型のコロニー刺激因子―１
DE3785864T2 (de) Verfahren zur Herstellung von menschlichem Epidermalwachstumsfaktor und dessen Analogen.
DE19605657B4 (de) Menschliches Proinsulinderivat, Kodierende DNA, DNA enthaltender Expressionsvektor, mit diesem transformierter Mikroorganismus und Verwendung dieses menschlichen Proinsulinderivats
DE3850690T2 (de) Basic fibroblast growth factor mutein, DNS und deren Verwendung.
DE60121808T2 (de) Verwendung eines polypeptids, welches die extrazelluläre domäne von il-20ra und il-20rb enthält, zur behandlung von entzündungen
DE69007975T2 (de) Fusionsprotein bestehend aus gm-csf und il-3.
DE3856203T2 (de) Produktion von gereinigtem, biologisch aktivem, bakteriell hergestelltem human-csf-1
EP0769020B1 (de) NEUE hIL-4-MUTANTENPROTEINE ALS ANTAGONISTEN ODER PARTIELLE AGONISTEN DES HUMANEN INTERLEUKIN 4
DE69024104T2 (de) Polypeptide und Polypeptidanaloge mit inhibitorischer Aktivität gegenüber menschlicher Elastase
EP0401508A2 (de) Proteinaseninhibitoren, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE102004058306A1 (de) Verfahren zur Herstellung von Carboxy-terminal amidierten Peptiden
DE69028499T2 (de) Neues Verfahren zur Produktion von nichtfusioniertem Protein in E. coli
DD155004A5 (de) Verfahren zur herstellung eines dns-transfervektors
DE3751081T2 (de) [Leu 13] Motilin, dessen kodierende DNS-Moleküle und Verfahren zu dessen Herstellung.
EP0870030A1 (de) Polypeptide mit il-16-aktivität, verfahren zu ihrer herstellung und verwendung
DE19547933A1 (de) Multimere Formen von IL-16, Verfahren zu ihrer Herstellung und Verwendung
DE69115270T2 (de) Protein mit fibroblasten-wachstumsfaktor-rezeptoraktivität.
EP0544293B1 (de) Verfahren zur gentechnologischen Herstellung von biologisch aktivem beta-NGF
DE69219242T2 (de) Muteine des menschlichen Parathormons und ihre Herstellung
DE68927009T2 (de) EXPRESSION UND PROZESSIERUNG VON ACETYLIERTEN FGFs IN HEFEN
DE3853380T2 (de) Physiologisch aktives Lymphotoxin.
EP0904374A1 (de) Prozessierte polypeptide mit il-16-aktivität, verfahren zu ihrer herstellung und verwendung

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8131 Rejection